Invivyd
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
About Invivyd
Invivyd is a commercial-stage biopharmaceutical company that delivers protection from serious viral infectious diseases. It is on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2.
Company Facts
- Headquarters
- Waltham
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00101_00250
- Funding Stage
- ipo
- Total Funding
- $678,500,000
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2025-11-17
- Website
- invivyd.com
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Links
Canonical: https://fsome.com/organization/invivyd-3239 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.